Inari Medical Stock Gets RS Rating Upgrade

Blockhead

2024-12-12

On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

↑ X

RS Line vs. RS Rating: Which Is The Better Stock Indicator?

See All Videos

NOW PLAYING RS Line vs. RS Rating: Which Is The Better Stock Indicator?

This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.

Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.

How To Invest In Stocks In Both Bull And Bear Markets

Is Inari Medical Stock A Buy?

Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.

The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.

Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), LeMaitre Vascular (LMAT) and Insulet (PODD) are among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

MarketSurge's Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2490815783"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490815783\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2490815783?lang=zh_TW&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg","is_english":true,"pubTime":"2024-12-12 03:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490815783","market":"us","top_or_hot":-1,"title":"Inari Medical Stock Gets RS Rating Upgrade","media":"Blockhead","content":"<html><body><div>\n<p>On Wednesday, <b>Inari Medical</b> (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.</p>\n<span>\n<span>\n<span jw-video-key=\"6xjZJt10\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"11/19/2024\" vid-date-tmsp=\"1732025282\" vid-dom-id=\"9524406-675a09194e6a9\" vid-id=\"9524406\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/11/6xjZJt10-640x360.jpg\" vid-name=\"RS Line vs. RS Rating: Which Is The Better Stock Indicator?\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/6xjZJt10.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>RS Line vs. RS Rating: Which Is The Better Stock Indicator?</span>\n</span>\n</span>\n</span>\n</span>\n<p>This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.</p>\n<p>Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.</p>\n<hr/>\n<p>How To Invest In Stocks In Both Bull And Bear Markets</p>\n<hr/>\n<h2>Is Inari Medical Stock A Buy?</h2>\n<p>Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.</p>\n<div><div></div></div>\n<p>The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.</p>\n<p>Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. <b>Globus Medical</b> (GMED), <b>LeMaitre Vascular</b> (LMAT) and <b>Insulet</b> (PODD) are among the top 5 highly rated stocks within the group.</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p><span>MarketSurge's Tools Can Help The Individual Investor</span></p>\n<p><span>IBD Live: A New Tool For Daily Stock Market Analysis</span></p>\n<p><span>Profit From Short-Term Trends With SwingTrader</span></p>\n<p><span>How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks</span></p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inari Medical Stock Gets RS Rating Upgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInari Medical Stock Gets RS Rating Upgrade\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Blockhead</strong><span class=\"h-time small\">2024-12-12 03:59</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p>On Wednesday, <b>Inari Medical</b> (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.</p>\n<span>\n<span>\n<span jw-video-key=\"6xjZJt10\" vid-authors=\"RACHEL FOX\" vid-cat=\"Investor's Corner\" vid-date=\"11/19/2024\" vid-date-tmsp=\"1732025282\" vid-dom-id=\"9524406-675a09194e6a9\" vid-id=\"9524406\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/11/6xjZJt10-640x360.jpg\" vid-name=\"RS Line vs. RS Rating: Which Is The Better Stock Indicator?\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/6xjZJt10.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>RS Line vs. RS Rating: Which Is The Better Stock Indicator?</span>\n</span>\n</span>\n</span>\n</span>\n<p>This proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.</p>\n<p>Over 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.</p>\n<hr/>\n<p>How To Invest In Stocks In Both Bull And Bear Markets</p>\n<hr/>\n<h2>Is Inari Medical Stock A Buy?</h2>\n<p>Inari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.</p>\n<div><div></div></div>\n<p>The medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.</p>\n<p>Inari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. <b>Globus Medical</b> (GMED), <b>LeMaitre Vascular</b> (LMAT) and <b>Insulet</b> (PODD) are among the top 5 highly rated stocks within the group.</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p><span>MarketSurge's Tools Can Help The Individual Investor</span></p>\n<p><span>IBD Live: A New Tool For Daily Stock Market Analysis</span></p>\n<p><span>Profit From Short-Term Trends With SwingTrader</span></p>\n<p><span>How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks</span></p>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/\">Blockhead</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RS","symbol_name":"Reliance Steel & Aluminum Co","start_time":0,"source_url":"https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/","article_id":"2490815783","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490815783","pubTimestamp":1733947140,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"RS":"Reliance Steel & Aluminum Co","NARI":"Inari Medical, Inc."},"translate_title":"伊那里医疗股票获得RS评级升级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NARI":1,"RS":1},"content_text":"On Wednesday, Inari Medical (NARI) stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.\n\n\n\n↑\nX\n\n\n\n\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nRS Line vs. RS Rating: Which Is The Better Stock Indicator?\n\n\n\n\nThis proprietary rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.\nOver 100 years of market history shows that the best-performing stocks tend to have an RS Rating north of 80 as they launch their largest climbs. See if Inari Medical stock can continue to show renewed price strength and hit that benchmark.\n\nHow To Invest In Stocks In Both Bull And Bear Markets\n\nIs Inari Medical Stock A Buy?\nInari Medical stock is now considered extended and out of buy range after clearing a 53.67 buy point in a first-stage cup with handle. See if the medical stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.\n\nThe medical device company posted 0% earnings growth in the latest quarterly report. Revenue rose 21%.\nInari Medical stock earns the No. 50 rank among its peers in the Medical-Products industry group. Globus Medical (GMED), LeMaitre Vascular (LMAT) and Insulet (PODD) are among the top 5 highly rated stocks within the group.\nYOU MAY ALSO LIKE:\nMarketSurge's Tools Can Help The Individual Investor\nIBD Live: A New Tool For Daily Stock Market Analysis\nProfit From Short-Term Trends With SwingTrader\nHow To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}